Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
A New Model of CMT1A Using Dental Stem Cells: Calling for Tooth Donors
…Schwann cells behaving just as they do in CMT1A. What is This CMT Research Opportunity? This CMT research opportunity is your chance to further the understanding of how CMT1A works…
CMT Type 1
Charcot-Marie-Tooth disease Type 1 (CMT1) What is CMT Type 1? CMT Type 1 (CMT1) is defined as an autosomal dominant (see inheritance) demyelinating form of CMT. CMT1 accounts for about…
CMTAreportspring24FINALwebSPREADS
CMTA-STAR Biotech & Alliance Partners
…RESEARCH FOR DEMYELINATING CMT (Click image to enlarge) RESEARCH FOR AXONAL CMT CMTA-STAR ALLIANCE PARTNERS Actio Biosciences Actio Biosciences was founded by leaders in genetics and drug development to push…
CMTA Staff
…(STAR) and STAR Advisory Board, a group of 30 of the world’s leading CMT clinicians and scientists charged with shaping and delivering the CMTA’s research strategies. CMTA currently has more…
Tratamiento y Gestión de CMT
Tratamiento y Gestión de CMT El tratamiento de laCMT se hace en conjunto con los profesionales médicos de distintas especialidades. Después del diagnóstico por un neurólogo, los pacientes de CMT…
Genes, Genetics and Genealogy: Three Roadmaps for CMT
…of autosomal dominant CMT Type 2T, characterized by late-onset axonal CMT, usually starting around age 50. Finally, I knew—2T. Four generations of my family have had CMT symptoms consistent with…
CMTAWinter2023webspreads
CMTA Report_Winter 2024 – STAR Special Edition_Download
Research in Charcot–Marie–Tooth Disease Type 1A (CMT1A)
CMT1A Research Since 2008, the CMTA-STAR has made historic progress in developing a treatment for CMT1A. The chart above shows the major milestones we have reached. View the projects currently…